1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 2:Descriptive statistics of low-grade astrocytomas
Tumor Type* n (%) Parameter Mean/SD/SE 95% CI for Mean Range PAS (I/IV) 10/75 (13.33) rCBVT 1.71/0.45/0.14 1.39–2.03 0.84–2.52 rCBVP 0.97/0.14/0.05 0.87–1.07 0.77–1.29 DAS (II/IV) 14/75 (18.67) rCBVT 1.78/0.35/0.09 1.58–1.98 1.29–2.43 rCBVP 1.28/0.19/0.05 1.17–1.39 1.07–1.86
Note.—PAS indicates pilocytic astrocytoma; DAS, diffuse astrocytoma; rCBVT, tumoral relative cerebral blood volume; rCBVP, peritumoral relative cerebral blood volume.
* Roman numerals in parentheses show tumor grade according to the World Health Organization 2000 classification scheme.